Skip to main content

Table 1 The half maximal inhibitory dose (IC50), half maximal cytotoxic concentration (CC50), and half maximal cytomorbidity concentration (MC50) for each compound

From: Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives

Drug name IC50 (µg/ml) IC50 (uM) CC50 (µg/ml) CC50 (µM) MC50 (µg/ml) MC50 (µM)
Hydroxychloroquine 19 43.78 NA NA 39.8 91.72
Nitazoxanide NA NA 1.36 4.43 2.82 9.18
Oleuropein NA NA NA NA 24 44.40
Gamma-mangostin NA NA 3.31 8.35 1.47 3.70
DidemninB 0.04 0.36 NA NA 0.013 0.12
Cycloheximide 0.0002 0.0007 0.0022 0.0078 0.000054 0.00019
Remdesivir 0.83 1.38 96.2 159.64 67.3 111.68
Ribavirin NA NA NA NA 26.1 106.88
CyclosporineA NA NA 57.3 47.65 13.6 11.31
Linoleic acid 17.7 63.9 40.2 144.9 18.2 65.6